ResearcherUniversity of California, Los AngelesActive in the last 2 years
Daniel A. Low
Matched on ORCID iD 0000-0002-6425-9228; OpenAlex author ID A5091674984. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2018: 1 paper · 2019: 1 trial · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label… Co-author DOI 10.1016/j.radonc.2023.110064↗
- A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable… Co-author DOI 10.1016/j.ijrobp.2023.05.023↗
- Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System. Co-author DOI 10.1016/j.adro.2021.100682↗
- Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer: A Promising Approach. Co-author DOI 10.7759/cureus.2324↗
Trials 1
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Percy P. Lee · 4 shared papers, 1 shared trial, 2018–2024 · strength 0.69
- Trial Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer NCT03621644↗
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Parag Jitendra Parikh · 2 shared papers, 1 shared trial, 2019–2024 · strength 0.48
- Trial Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer NCT03621644↗
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Michael Frederick Bassetti · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Michael David Chuong · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- John Ng · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Luca Boldrini · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Kathryn Elizabeth Mittauer · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Alex T. Price · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Lorenzo Placidi · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Lorraine Portelance · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Bassem I. Zaki · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Hyun Jee Kim · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Lauren E. Henke · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- James M. Lamb · 2 shared papers, 2018–2021 · strength 0.21
- Paper Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System. DOI 10.1016/j.adro.2021.100682↗
- Paper Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer: A Promising Approach. DOI 10.7759/cureus.2324↗
- Michael Chuong · 1 shared trial, 2019 · strength 0.21
- Phillip E. Chow · 1 shared paper, 2021 · strength 0.12
- Elaine Luterstein · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.